Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Who We Help
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Who We Help
Who We Help/
WHO WE HELP
  • Pharmaceutical Manufacturers
  • Emerging Biopharma
  • MedTech
  • Financial Institutions
  • Government and Public Health
  • Health Plans
  • Hospital and Health Systems
  • Insurers and Risk
  • Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers

Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.

Discover More
Pharmaceutical Manufacturers
Emerging Biopharma (Global page)

Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.

Discover Innovations
MedTech

Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.

Explore MedTech
MedTech
Financial Institutions

Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.

Access Insights
Government and Public Health

Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.

Unlock Innovations
Government and Public Health
Health Plans

Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.

Navigate Health Plans
Hospital and Health Systems

Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.

Streamline Decisions
Hospital and Health Systems
Insurers and Risk

Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.

Uncover More
Medical Specialty and Patient Advocacy

Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.

Explore Now
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS

PODCASTS

"Discover the future through our enlightening podcasts available in the United States.

EXPLORE PODCASTS

FACT SHEET

"IQVIA AI Medical Record Review

LEARN MORE

BLOG

"Decoding DSCSA: Ensuring Compliance in the Pharmaceutical Supply Chain

READ MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

WATCH ON-DEMAND WEBINARS
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

DISCOVER EVENTS & WEBINARS

EVENT

"26th Controlled Substances and State Regulatory Conference

REGISTER NOW
MAIN/Contact Us
Contact Us/
Blog
Expanding Business into Ambulatory Surgery Centers
Kristin Brillant, Director, Product Offering, IQVIA MedTech, U.S
Carolina Bueno, Associate Director, Product & Strategy, Commercial, IQVIA MedTech, U.S.
Mar 04, 2024

It’s no secret that the Ambulatory Surgery Center (ASC) space has grown exponentially1 over the last six years as there has been a significant amount of procedures that were historically being performed in a traditional hospital setting now shifting to ASCs. When given the choice, more and more patients are choosing smaller outpatient care facilities like ASCs, rather than hospitals, for outpatient surgeries due to the lower costs, flexibility in scheduling, and more personalized care from physicians and staff.

Between 2014 and 2020, the number of Medicare-certified ASCs increased by 11% and the volume of Medicare payments for ASC procedures increased by 29%. This segment is expected to see 25% growth2 in procedural volume over the next four years, and with more than 93% of ASCs having some measure of physician ownership, we can see how they too are opting for ASCs as their site of choice for performing surgery. Often, being a part owner in the center affords them more freedom of choice and management over equipment, staff, and scheduling. Moreover, procedures performed in an ASC where a physician has ownership could represent higher earning potential.

The Centers for Medicare and Medicaid Services are also migrating many procedures that have been traditionally performed only in the hospital setting to ASCs. Private payers are following the same trend and enacting policies to drive procedures to ASCs. These changes are positively impacting the healthcare system landscape, thus fueling growth and demand.

Three Trends Affecting MedTech Go-to-Market Strategies

Nonetheless, this $36 billion industry3 can remain difficult to understand as many companies try to enter the space by pushing for failing solutions and strategies that are tailored predominantly to traditional hospitals. To be successful in ASCs, it is crucial for MedTech companies to listen and understand the needs of the business. It is equally important to understand the differences in the way an ASC operates versus a traditional hospital and use this as a competitive advantage to create a partnership and implement comprehensive, tailored solutions.

IQVIA MedTech experts detail three key strategies companies should keep in mind when entering the ASC space:

ASC migration

The transition from hospitals to outpatient care facilities has started and it’s here to stay. The ASC space is expected to grow from $36.69 billion (in 2021) to $58.85 billion by 2028, at a 7% compound annual growth rate (CAGR).4 One of the key contributing factors to this migration is that ASCs can largely perform the same procedures as hospitals for about half the cost with equal, if not better, clinical outcomes. This is something that health plans continue to recognize and incentivize.

MedTech companies should not fight this migration, but rather, embrace it by creating meaningful partnerships that further alleviate growing pains and aid overall business growth in this area.

ASCs ≠ HOPDs

ASCs are different than hospital-based outpatient departments (HOPDs), and one of the biggest mistakes that MedTech companies can make when entering the ASC space is to approach them with the same strategy as hospitals. ASCs, by design, are different than hospitals; they have smaller infrastructures, fewer and smaller operating rooms, inventory constraints due to geographical and space challenges, faster patient flow, and different scheduling capabilities. ASCs also have more financial constraints and, often, limitations within their internal business operating systems. Therefore, solutions that have historically worked in the HOPD cannot be forced into the ASC. In return, this is an opportunity for MedTech companies to craft customized solutions that will foster growth in all the right areas.

ASCs have specific needs

We’ve all been guilty of jumping into solution mode without first thoroughly understanding the problem. Before jumping in, first listen and understand the needs, concerns, and challenges of the individual ASC with which you are working. As MedTech companies tap into the ASC opportunity, they need to keep three things at the front and center: Listen first, understand specific challenges, and know that often, one size does not fit all.

MedTech companies can leverage these insights to create customized solutions that will address the challenges and concerns of their specific ASC customer. Here are some solutions that can successfully equip you to become a true ASC partner:

  • Understanding changes in industry dynamics.
  • Analyzing procedural volume data and shifts in site-of-care where procedures are being performed.
  • Identifying and understanding shifts in demand.
  • Understanding physician ownership.
  • Obtaining insight into healthcare professionals and the facilities at which they perform procedures.
  • Determining physician and market-level share.
  • Utilizing reliable data quality and stakeholder insights.
  • Targeting the right facilities.
  • Understanding the needs of the underserved opportunities.
  • Leveraging industry-leading data to optimize sales territory planning and initiatives.

Learn how IQVIA’s MedTech Market Activator and Claims Data Solutions can help.

 

References:

  1. Three Trends Affecting MedTech Go-to-Market Strategies.
  2. MedTech Strategies to Win in the Ambulatory Surgery Center Market. 
  3. Munnich EL, Richards MR. Long-run growth of ambulatory surgery centers 1990–2015 and Medicare payment policy. Health Serv Res. 2022; 57(1): 66-71. https://doi.org/10.1111/1475-6773.13707.
  4. Fortune Business Insights, US Ambulatory Surgery Center Market Report 2022. https://www.fortunebusinessinsights.com/u-s-ambulatory-surgical-centers-market-106323

Related solutions

Contact Us